1 "Implant Failure" clinical trial found.

• 

  Strategic Management to Optimize Response to Cardiac Resynchronization Therapy

  WIRB will be the Main IRB and Penn will be the relying IRB. NYHA Class I-II patients are now eligible ...

  Free text  Robert Schaller